RAM
NVAX icon

Reflection Asset Management’s Novavax NVAX Stock Holding History

Reflection Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$183 Buy
+25
New +$188 ﹤0.01% 499

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Reflection Asset Management's NVAX Position: Q4 2025 in Review

Reflection Asset Management opened a new position in Novavax (NVAX) in Q4 2025: 25 shares worth $183. The stake represents ﹤0.01% of the portfolio and ranks #499 among its holdings.

235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • Reflection Asset Management held 25 shares of Novavax worth $183 as of Q4 2025.
  • Novavax was a new Reflection Asset Management position in Q4 2025.
  • Novavax made up ﹤0.01% of Reflection Asset Management's portfolio in Q4 2025, its #499 holding.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on Reflection Asset Management's 13F filing for Q4 2025, filed 2 Mar 2026.